EconPapers    
Economics at your fingertips  
 

Building Consensus for Molecular Tumor Board Implementation in Europe: a Delphi procedure

Luigi Russo, Nicolò Lentini, Erika Giacobini, Alessandra Sabatelli, Tommaso Osti, Maud Kamal, Roberta Pastorino and Stefania Boccia

No a73hb_v1, SocArXiv from Center for Open Science

Abstract: Background: Molecular Tumor Boards (MTBs) integrate molecular and clinical data to guide precision oncology decisions. However, their structure and functioning remain highly heterogeneous across Europe. This study aimed to develop consensus-based policy recommendations to support their harmonized implementation. Methods: A two-round Delphi process was conducted among 17 European experts actively involved in MTBs. Questionnaire items were derived from a systematic and scoping review on the clinical impact and implementation aspects of MTBs. Experts rated items on a five-point Likert scale, with consensus predefined as a Content Validity Index (CVI) ≥ 80% of experts agreeing or strongly agreeing (scores 4-5). Results: Across two Delphi rounds, 76 items were evaluated. Thirty-six achieved consensus and were consolidated into 15 recommendations across four domains: organizational aspects (n = 8), testing (n = 3), inclusion criteria (n = 2), and clinical aspects (n = 2). Organizational standards emphasized the appointment of a referent clinician, the use of standardized digital submission tools, online meeting formats, and the integration of decision-support systems. The recommended MTB composition was multidisciplinary, including oncologists, molecular biologists, pathologists, geneticists, and other relevant specialists. In the testing domain, experts agreed that NGS should be the preferred approach for molecular profiling, conducted in certified laboratories, with variant interpretation supported by curated databases (e.g., ClinVar, COSMIC, OncoKB). Inclusion criteria prioritized patients with metastatic or rare diseases, ECOG performance status 0–2, life expectancy ≥12 weeks, and exhaustion of standard therapeutic options. Conclusions: This Delphi consensus produced 15 policy recommendations to standardize and sustain MTBs across Europe. These guidelines complement existing frameworks by providing practical operational guidance for precision oncology implementation.

Date: 2025-10-16
References: Add references at CitEc
Citations:

Downloads: (external link)
https://osf.io/download/68f0a5978759605e1c4973cb/

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:osf:socarx:a73hb_v1

DOI: 10.31219/osf.io/a73hb_v1

Access Statistics for this paper

More papers in SocArXiv from Center for Open Science
Bibliographic data for series maintained by OSF ().

 
Page updated 2025-10-18
Handle: RePEc:osf:socarx:a73hb_v1